LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||
Cash flow from continuing operating activities | -4M | 2M | -9M | -13M | -10M |
Net income from continuing operations | --15M | --134M | ---73M | ---142M | ---123M |
Operating gains losses | ---23M | ---173M | --90M | --164M | --182M |
Depreciation and amortization | --0 | --0 | --0 | --0 | --0 |
Deferred tax | --5M | --36M | ---20M | ---37M | ---32M |
Other non cash items | --0 | ---- | ---- | ---- | ---- |
Change In working capital | ---2M | --5M | ---7M | --0 | ---4M |
-Change in payables and accrued expense | --0 | --0 | ---4M | --5M | ---9M |
-Change in other current assets | ---2M | --5M | ---3M | ---5M | --5M |
Cash from discontinued investing activities | |||||
Operating cash flow | ---4M | --2M | ---9M | ---13M | ---10M |
Investing cash flow | |||||
Cash flow from continuing investing activities | -3M | 108M | 0 | 1M | 0 |
Capital expenditure reported | --0 | --0 | --0 | --0 | --0 |
Net business purchase and sale | ---3M | --107M | --0 | ---3M | ---4M |
Net investment purchase and sale | ---- | ---- | ---- | --1M | ---- |
Net other investing changes | --0 | ---- | ---- | --3M | ---- |
Cash from discontinued investing activities | |||||
Investing cash flow | ---3M | --108M | --0 | --1M | --0 |
Financing cash flow | |||||
Cash flow from continuing financing activities | -11M | -2M | 2M | 317M | 0 |
Net issuance payments of debt | ---12M | --0 | --0 | --217M | --0 |
Net other financing activities | ---- | ---- | --2M | --100M | --0 |
Cash from discontinued financing activities | |||||
Financing cash flow | ---11M | ---2M | --2M | --317M | --0 |
Net cash flow | |||||
Beginning cash position | --406M | --298M | --305M | ---- | ---- |
Current changes in cash | ---18M | --108M | ---7M | --305M | ---- |
Effect of exchange rate changes | ---- | ---- | ---- | --0 | ---- |
End cash Position | --388M | --406M | --298M | --305M | --305M |
Free cash flow | ---4M | --2M | ---9M | ---13M | ---10M |
Currency Unit | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- |